Risk of Needle Track Seeding Following Biopsy for HCC is 2.7%

Risk of Needle Track Seeding Following Biopsy for HCC is 2.7% Risk of Needle Track Seeding Following Biopsy for HCC is 2.7% The risk of the spread of cancer along the path of the needle (needle track seeding) during a biopsy for hepatocellular carcinoma (HCC) is approximately 2.7%. These results were recently published in the journal Gut. The liver is the largest organ in the body and is responsible for over 500 functions, including the secretion of glucose, proteins, vitamins and fats; the production of bile; the processing of hemoglobin and detoxification of numerous substances